Link Pharma Chem Ltd.
BSE: LINKPH · Commodity Chemicals · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 70 companies in Commodity Chemicals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹1 cr vs borrowings ₹7 cr (FY26): borrowings are higher by ₹7 cr.
- Operating profit covered interest 1.0x in the last 12 months.
- Net loss in 2 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹25.45 on 2026-10-26: -30.3% from the 52-week high, +21.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 6 | 8 | 6 | 7 | 7 | 9 |
| EBITDA | -0 | 1 | 0 | 1 | -0 | 0 |
| OPM % | -3.4% | 8.2% | 5.4% | 10.4% | -3.6% | 5.2% |
| Other income | 0 | 0 | 0 | -0 | 0 | 0 |
| Net profit | -0 | 0 | 0 | 0 | -0 | 0 |
| EPS (₹) | 0.79 | 0.91 | 0.03 | 0.15 | 0.92 | 0.72 |
| Revenue YoY | +2.2% | +12.3% | ||||
| Profit YoY | – | -20.0% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 54 | 39 | 30 | 25 | 27 | 28 |
| EBITDA | 4 | 3 | -1 | 0 | 1 | 1 |
| Net profit | 2 | 1 | -1 | -1 | 0 | -0 |
| EPS (₹) | 4.24 | 1.47 | -3.07 | 2.31 | 0.17 | 1.82 |
| Revenue growth | -27.6% | -22.9% | -14.9% | +7.9% | – | |
| Profit growth | -65.4% | -309.2% | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -10.9% | – | – |
| Net profit | -50.9% | – | – |
| EPS | -51.3% | – | – |
| Share price | – | -20.1% (2y) | -27.6% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 13 | 13 |
| Borrowings | 6 | 7 |
| Cash & equivalents | 0 | 1 |
| Total assets | 23 | 25 |
| Fixed assets | 9 | 10 |
| Capital work in progress | 0 | 0 |
| Investments | 2 | 2 |
| Receivables | 5 | 5 |
| Inventory | 6 | 5 |
| Payables | 3 | 3 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 3 | 2 |
| Cash from investing | 2 | -3 |
| Cash from financing | -4 | 1 |
| Capex | 0 | 2 |
| Free cash flow | 2 | 0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -8.1% | 0.6% |
| ROCE % | -3.4% | 3.3% |
| Debtor days | 72 | 70 |
| Inventory days | 167 | 170 |
| Payable days | 101 | 110 |
| Cash conversion cycle (days) | 138 | 130 |
| Working capital days | 16 | 1 |
Peers in Commodity Chemicals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SRF | ₹69,362 cr | 30.4x | 4.5x | 16.0% | 15.2% | 21.4% | +373.5% | 0.38% |
| TATACHEM | ₹15,184 cr | – | 0.7x | -10.1% | -4.2% | -1.6% | -4.6% | 1.84% |
| DEEPAKFERT | ₹14,422 cr | 14.7x | 2.1x | 15.1% | 13.6% | 16.7% | +0.6% | 0.89% |
| GNFC | ₹7,634 cr | 7.4x | 0.8x | 11.7% | 15.2% | 14.8% | -8.7% | 3.41% |
| TANFACIND | ₹4,989 cr | 66.3x | 13.4x | 19.7% | 20.5% | 15.5% | +23.8% | – |
| GUJALKALI | ₹4,043 cr | 60.9x | 0.8x | 1.2% | 3.6% | 11.3% | -1.2% | 2.88% |
| GRAUWEIL | ₹3,537 cr | 22.1x | 3.3x | 15.9% | 19.6% | 15.3% | +6.8% | 0.64% |
| GHCL | ₹3,486 cr | 6.7x | 1.0x | 14.9% | 19.9% | 24.8% | -12.3% | 3.29% |
| JGCHEM | ₹2,190 cr | 29.1x | 4.1x | 15.1% | 19.8% | 8.9% | – | 0.18% |
| LINKPH | ₹11 cr | 14.0x | 0.9x | -0.1% | 2.9% | 4.4% | -10.9% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Commodities |
| Industry | Commodity Chemicals |
| Sub-industry | Commodity Chemicals |
| Symbol | LINKPH |
| BSE code | 524748 |
| ISIN | INE302F01011 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.